Presentation is loading. Please wait.

Presentation is loading. Please wait.

Mathieu Verbeken1, Romain Lefebvre2, Els Goossens3, Walter Luyten4,

Similar presentations


Presentation on theme: "Mathieu Verbeken1, Romain Lefebvre2, Els Goossens3, Walter Luyten4,"— Presentation transcript:

1 Purity profiling and the associated functional effects of a new peptide
Mathieu Verbeken1, Romain Lefebvre2, Els Goossens3, Walter Luyten4, Liliane Schoofs5 and Bart De Spiegeleer1,* 1 DruQuaR (Drug Quality and Registration) group, Faculty of Pharmaceutical Sciences, Ghent University, Harelbekestraat 72, B-9000 Ghent, Belgium 2 Department of Pharmacology, Faculty of Medicine and Health Sciences, Ghent University, De Pintelaan 185, B-9000 Ghent, Belgium 3 VAR-CODA-CERVA, Groeselenberg 99, B-1180 Ukkel, Belgium 4 Faculty of Biology, Leuven University, Naamsestraat 59 box 2469, B-3000 Leuven, Belgium 5 Department of Animal Physiology and Neurobiology, Faculty of Biology, Leuven University, Naamsestraat 59 box 2469, B-3000 Leuven, Belgium *Corresponding author: Tel.: ; Fax: , b

2 1. Introduction 1. Introduction 2. Objective 3. Methods 4. Results 5. Conclusion Identification of new peptides or peptide leads with the potential of serving as a basis towards new peptidic drugs! [1] Croner B. Peptides as drugs: Discovery and development. Wiley VCH (2002). BGFW Forum Spa DruQuaR, Fac. Pharm. Sciences, Ghent University

3 1. Introduction Mouse peptidomics Synthetic peptides
2. Objective 3. Methods 4. Results 5. Conclusion Mouse peptidomics Synthetic peptides Functional screening Decision: Yes/No BGFW Forum Spa DruQuaR, Fac. Pharm. Sciences, Ghent University

4 2. Objective Knowing: small changes in peptide structure
1. Introduction 2. Objective 3. Methods 4. Results 5. Conclusion Knowing: small changes in peptide structure big functionality changes Initially “active” peptide coded SBO215_7: impurity profiling functionality ? BGFW Forum Spa DruQuaR, Fac. Pharm. Sciences, Ghent University

5 3. Methods - Functionality
1. Introduction 2. Objective 3. Methods 4. Results 5. Conclusion Tissue organ bath (TOB) experiments – screening of a peptide-database: Principle: In vitro recording of smooth muscle contractions in isolated preparations using a force transducer Tissues (isolated): Mouse vas deferens Rat aortic ring Guinea pig ileum and trachea Screening: administration of peptides and interpretation of smooth muscle recordings BGFW Forum Spa DruQuaR, Fac. Pharm. Sciences, Ghent University

6 3. Methods - Analytics 1. Introduction 2. Objective 3. Methods 4. Results 5. Conclusion HPLC-DAD/UV-ESI/iontrap MSn: Column: Grace/Vydac C18 monomeric (+ guard), 250 x 4.6 mm, 5 µm Column temperature: 30°C Gradient method: in 45 min from 95:5 H2O/ACN % FA (m/V) to 5:95 H2O/ACN % FA (m/V) Flow rate: 1.0 ml Detection: from 195 nm to 400 nm [quantification: 210 nm] BGFW Forum Spa DruQuaR, Fac. Pharm. Sciences, Ghent University

7 Crude vs. high purity peptide material (one supplier)
4. Results 1. Introduction 2. Objective 3. Methods 4. Results 5. Conclusion TOB results of a peptide coded SBO215_7 – baseline induced contractions: Crude vs. high purity peptide material (one supplier) Guinea pig ileum BGFW Forum Spa DruQuaR, Fac. Pharm. Sciences, Ghent University

8 Three crude suppliers vs. a high purity peptide: 10-4 M
4. Results 1. Introduction 2. Objective 3. Methods 4. Results 5. Conclusion Three crude suppliers vs. a high purity peptide: 10-4 M Guinea pig ileum GLB > 95 % GLB The Sci Pi Prot BGFW Forum Spa DruQuaR, Fac. Pharm. Sciences, Ghent University

9 4. Results GLB GLB > 95 % NOT OR Three HPLC peaks The Sci Pi Prot
Requirements for the synthesis related impurity causing the functional effect: 1. Introduction 2. Objective 3. Methods 4. Results 5. Conclusion Reporting threshold: 0.5 % List up impurities using Boolean operators: Yes/No GLB GLB > 95 % NOT OR Three HPLC peaks of peptide synthesis related impurities (in range of 10-6 M) The Sci Pi Prot BUT AND Currently: identification MSn Synthesis for confirmation Functionality on GPI Observation: completely different impurity-quality profile BGFW Forum Spa DruQuaR, Fac. Pharm. Sciences, Ghent University

10 5. Conclusion 1. Introduction 2. Objective 3. Methods 4. Results 5. Conclusion Functionality screening of new peptides in tissue bath experiments: Quality aspects are generally neglected in this phase of investigation, leading to wrong fail/pass decisions: e.g. crude vs high purity SBO215_7 material: different pharmacological outcome due to low level impurities QUALITY OF PEPTIDES IS AN IMPORTANT ASPECT IN THEIR FUNCTIONAL SCREENING USING TOB EXPERIMENTS TO AVOID FALSE POSITIVE FUNCTIONALITY CONCLUSIONS. BGFW Forum Spa DruQuaR, Fac. Pharm. Sciences, Ghent University

11 Thank you for your attention!!!
BGFW Forum Spa DruQuaR, Fac. Pharm. Sciences, Ghent University


Download ppt "Mathieu Verbeken1, Romain Lefebvre2, Els Goossens3, Walter Luyten4,"

Similar presentations


Ads by Google